Home NDC 0061-2321 NDC 0061-2321 - Orbax This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0061-2321
Package NDCs from labels 0061-2321-01
Manufacturer Merck Sharp & Dohme Corp.
Effective date 2025-12-19
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0061-2321-01 Orbax 1 in 1 CARTON SUSPENSION 1 9 0061-2321-01 Orbax 20 mL in 1 BOTTLE, PLASTIC SUSPENSION 20 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0061-2321 ORBAX (ORBIFLOXACIN) SUSPENSION [MERCK SHARP & DOHME CORP.] 6 2 package rows 20241103_4a4cabca-caa0-4df3-bc46-963f0804b54a.zip
DailyMed Socrata Ingredients# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.